SCHEMBL5726367

SCHEMBL5726367

CCOC(=O)CSc1ncc(Cc2cccs2)c(N)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 6/20 0.50
▸ ALDH1A1 P00352 4/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ MAPT P10636 4/20 0.47
▸ TSHR P16473 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ GAA P10253 1/20 0.42
▸ HIF1A Q16665 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726424 0.89 MAPT (0.41) ALDH1A1MAPK1HSD17B10MAPTTSHR
SCHEMBL5726595 0.85 ALDH1A1 (0.42) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5726249 0.83 ABCB1 (0.47) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5726364 0.83 ABCB1 (0.60) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5725943 0.82 ABCB1 (0.48) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5726497 0.82 ABCB1 (0.48) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5727637 0.82 ALDH1A1 (0.40) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5726257 0.80 ALDH1A1 (0.48) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5726381 0.80 ALDH1A1 (0.48) ABCB1ALDH1A1MAPK1HSD17B10MAPT
SCHEMBL5726637 0.80 ALDH1A1 (0.48) ABCB1ALDH1A1MAPK1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7138404-B2 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-21 — — US claimed
EP-1395568-B1 4-AMINOPYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-02 — — EP claimed
EP-1395568-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-03-10 — — EP claimed
US-20030022907-A1 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. 2003-01-30 — — US claimed
WO-2002094795-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-11-28 — — WO claimed
US-7138404-B2 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-21 — — US disclosed
EP-1395568-B1 4-AMINOPYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-11-02 — — EP disclosed
EP-1395568-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-03-10 — — EP disclosed
US-20030022907-A1 4-aminopyrimidine derivatives HOFFMANN-LA ROCHE INC. 2003-01-30 — — US disclosed
WO-2002094795-A1 4-AMINOPYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-11-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030022907-A1 4-aminopyrimidine derivatives GRM5, GRIK5, GRM1 ABCB1 510/4885ALDH1A1 786/4885MAPK1 1232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback